Ruminant Vaccines Market to Grow with a CAGR of 5.25% through 2028
Increasing global population and food demand and expanding
veterinary care and awareness are factors driving the Global Ruminant Vaccines Market in the forecast
period 2024-2028.
According to TechSci Research report, “Ruminant
Vaccines Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2028”, the Global Ruminant Vaccines Market
stood at USD 3.32 Billion in 2022 and is anticipated to grow with a CAGR of 5.25%
in the forecast period, 2024-2028. The global
ruminant vaccines market is experiencing substantial growth, driven by several
key factors that are reshaping the dynamics of this industry. Ruminants, which
include cattle, sheep, goats, and other related animals, are integral to the
global agriculture sector. As the demand for livestock products continues to
rise, the importance of maintaining healthy ruminant populations cannot be
overstated. One of the primary drivers of the global ruminant vaccines market is the
ever-growing global population. As more people inhabit the planet, the demand
for protein-rich animal products, such as beef, milk, and lamb, continues to
rise. Ruminants play a crucial role in meeting this demand, making their health
and productivity a priority. Vaccines are essential tools in preventing and
controlling diseases in these animals, ensuring a steady supply of safe and
high-quality food.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Ruminant Vaccines Market”
The international trade of livestock and
livestock products has surged in recent years. Export and import of ruminants
are commonplace, driven by factors like the globalization of food supply
chains, changing consumer preferences, and economic growth. With the increase
in livestock trade, the need for disease prevention and control becomes more
critical, making ruminant vaccines indispensable to global livestock health and
trade. There
has been a notable increase in awareness and concern for animal welfare,
health, and disease prevention. This growing awareness is fostering the
development of a more organized and sophisticated veterinary care system, which
includes vaccination programs for ruminants. Veterinary professionals,
livestock farmers, and governments are recognizing the significance of vaccines
in maintaining animal health and welfare, and are investing in their use and
development.
Many governments worldwide are actively
promoting livestock health and welfare through regulatory measures and support
for vaccination programs. These initiatives include subsidies, incentives, and
guidelines to encourage ruminant vaccination. In some cases, governments have
implemented strict regulations to ensure the health and safety of ruminant
populations, boosting the market for ruminant vaccines.
Zoonotic
diseases, which can be transmitted from animals to humans, have become a major
global concern. The emergence of zoonotic diseases has heightened the
importance of controlling diseases in ruminants to prevent spillover to humans.
Vaccination is a crucial component of zoonotic disease control, and this drives
the demand for ruminant vaccines.
The Global Ruminant Vaccines Market is segmented into animal
type, vaccine type, vaccine indication, route of administration and company.
Based on route of administration, the injectable segment
has emerged as the predominant market leader. Injectable vaccines offer precise
dosing, ensuring that animals receive the correct amount of the vaccine. This
accuracy is crucial in maintaining the vaccine's effectiveness and preventing
potential overdosing or underdosing. Injectable vaccines are known for their
ability to confer long-lasting immunity. This is particularly important in the
case of ruminants, as they often have longer lifespans than other livestock
animals. A single injection can provide protection for an extended period,
reducing the need for frequent booster shots. While administering vaccines,
especially in large herds, can be a time-consuming task, injectable vaccines
offer relative ease of administration. This is crucial for efficient
vaccination campaigns and reducing labor costs for farmers.
Based on region, North America segment is expected to
grow during the forecast period North America has been at the forefront of adopting
cutting-edge technologies in vaccine production and delivery. Modern
manufacturing techniques and advanced delivery systems enhance the efficacy of
ruminant vaccines while ensuring safety and convenience for both animals and
operators. The United States and Canada have well-established regulatory
frameworks for animal vaccines. This ensures that vaccines are rigorously tested
for safety and efficacy, instilling confidence in the products among farmers
and ranchers.
The Asia Pacific region is experiencing rapid market
growth. The region's governments and industry stakeholders are proactive in
monitoring and controlling livestock diseases. This preparedness and quick
response to potential epidemics have created a sense of stability and
confidence in the industry.
Major companies operating in Global Ruminant
Vaccines Market are:
- Boehringer Ingelheim International GmbH
- Zoetis Services LLC
- Vaxxinova International BV
- Merck & Co., Inc.
- Bimeda Animal Health Ltd.
- Indian Immunologicals Ltd.
- Elanco Animal Health Incorporated
- Virbac
- Ceva Santé Animale
- CZ Vaccines S.A.U. (Zendal Group)
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“The global ruminant vaccines market is propelled by a
combination of factors, including the growing global population, the expansion
of livestock trade, increasing awareness of animal health, government support
and regulations, zoonotic threats, technological advancements, and the impact
of climate change on disease spread. These market drivers underscore the
critical role of ruminant vaccines in ensuring the health and productivity of
these vital livestock populations, which, in turn, plays a crucial role in meeting
the world's growing demand for high-quality animal products.,” said Mr. Karan
Chechi, Research Director with TechSci Research, a research-based management
consulting firm.
“Ruminant Vaccines Market By Animal Type (Cattle,
Sheep & Goats), By Vaccine Type (Modified/ Attenuated Live, Inactivated
(Killed), Others), By Vaccines Indication
(BVD Infection, Bovine Respiratory Diseases (BRD), Leptospirosis, Clostridial
diseases, Diarrhea/ Scours, FMD, Others), By Route of Administration
(Injectable, Intranasal), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated
the future growth potential of Global Ruminant Vaccines Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Ruminant Vaccines Market.
Contact Us-
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
M:
+13322586602
Email: [email protected]
Website: www.techsciresearch.com